Try among the firms making the largest strikes noon: Staar Surgical — The implantable eye lens maker ripped 45% increased after agreeing to be purchased by Alcon for $28 per share in money, valuing Staar at about $1.5 billion. The deal is predicted to shut within the subsequent six to 12 months. DigitalOcean — The software program inventory rallied 27% on better-than-expected second-quarter outcomes. DigitalOcean additionally raised its full-year income and earnings steerage. Coinbase — The crypto trade dropped greater than 5% after promoting $2 billion in convertible senior bonds. Lattice Semiconductor — The semiconductor maker surged 9.5% after second-quarter income got here in at $124 million, topping the consensus forecast for $123.7 million from analysts polled by FactSet. Earnings per share, excluding one-time gadgets, matched expectations for the quarter at 24 cents per share. UFP Applied sciences — The medical parts producer surged 11% after posting second-quarter adjusted earnings of $2.50 per share, higher than the $2.25 per share estimated by analysts surveyed by FactSet. Income of $151.2 million =fell in need of an anticipated $151.6 million. Palantir Applied sciences — The protection know-how inventory jumped 6.8% after quarterly income exceeded $1 billion for the primary time and it raised full-year steerage. Palantir now anticipates income for the yr to vary between $4.142 billion and $4.150 billion, up from prior steerage of between $3.89 billion and $3.90 billion. Second-quarter earnings and income additionally topped expectations. Pfizer — The drugmaker rose 3.6% after elevating its steerage within the wake of second-quarter earnings and income that topped analysts’ estimates. Pfizer now expects full-year adjusted earnings between $2.90 and $3.10 per share versus earlier steerage of between $2.80 and $3 per share. Yum Manufacturers — The KFC, Taco Bell and Pizza Hut dad or mum dropped practically 4% after second-quarter outcomes missed expectations . Adjusted earnings of $1.44 per share had been 2 cents beneath the LSEG consensus estimate, whereas income of $1.93 billion lagged the $1.94 billion anticipated by analysts. Eaton — The ability administration firm dropped 6% after issuing weak third-quarter steerage. Eaton anticipates adjusted earnings of $3.01 to $3.07 per share, whereas analysts polled by LSEG anticipated $3.09 per share. Second-quarter earnings and income topped expectations. BP — U.S.-listed shares of the U.Ok.-based oil producer, previously British Petroleum, added 3% after BP’s quarterly revenue beat expectations . Dupont De Nemours — The chemical maker rose 3.3% after second-quarter adjusted earnings of $1.12 per share exceeded the $1.06 per share anticipated by analysts polled by LSEG. Income of $3.26 billion was above the $3.24 billion consensus estimate. Duke Power — The Charlotte-based utility rose 1.1% after second-quarter adjusted earnings of $1.25 per share exceeded the $1.18 per share analysts surveyed by FactSet had penciled in. Duke Power additionally reaffirmed its full-year adjusted earnings steerage of between $6.17 and $6.42 per share versus FactSet’s consensus analyst estimate of $6.32. Lemonade — The insurance coverage firm soared 29% after issuing better-than-expected full-year steerage. Lemonade expects income between $710 million and $715 million, up from a previous forecast of between $661 million and $663 million. Hims & Hers Well being — The telehealth firm pulled again 8% after second-quarter income of $545 million missed estimates from analysts polled by LSEG that referred to as for $552 million. The corporate’s forecast for third-quarter earnings earlier than curiosity, taxes, depreciation and amortization, or EBITDA, of $60 million to $70 million additionally missed analysts’ forecasts of $77 million. Axon Enterprise — The maker of tasers and different police merchandise climbed 14% after second-quarter earnings beat Avenue expectations and it raised full-year monetary steerage. Axon earned $2.12 per share, excluding one-time gadgets, on $669 million in income, whereas analysts surveyed by FactSet had estimated $1.45 per share on $641 million in income. For the complete yr, Axon sees income ranging between $2.65 billion and $2.73 billion, up from an earlier outlook for $2.60 billion to $2.70 billion and analysts’ consensus estimate of $2.66 billion. Syndax Prescribed drugs — Shares soared greater than 16% after the biopharmaceutical firm’s second-quarter income beat analysts’ expectations. Syndax additionally posted a narrower-than-expected loss per share. Gartner — The tech-focused advisory agency plunged practically 30% after issuing disappointing steerage. For the complete yr, Gartner sees adjusted earnings of a minimum of $11.75 per share and income of a minimum of $6.455 billion. Analysts polled by FactSet had been on the lookout for $12.48 per share in earnings and $6.57 billion in income. — CNBC’s Darla Mercado, Lisa Han and Alex Harring contributed reporting.
